187 related articles for article (PubMed ID: 31639806)
1. Dimethylarginine Dimethylaminohydrolase 1 Polymorphisms and Venous Intimal Hyperplasia in Hemodialysis Patients.
Wu CC; Hsieh MY; Lee CK; Chuang SY; Chung MY; Lin CC
Am J Nephrol; 2019; 50(6):454-464. PubMed ID: 31639806
[TBL] [Abstract][Full Text] [Related]
2. The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study.
Lu TM; Lin SJ; Lin MW; Hsu CP; Chung MY
Cardiovasc Diabetol; 2011 Feb; 10():16. PubMed ID: 21303562
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.
Lind L; Ingelsson E; Kumar J; Syvänen AC; Axelsson T; Teerlink T
Vasc Med; 2013 Aug; 18(4):192-9. PubMed ID: 23892448
[TBL] [Abstract][Full Text] [Related]
4. AGXT2 and DDAH-1 genetic variants are highly correlated with serum ADMA and SDMA levels and with incidence of coronary artery disease in Egyptians.
Amir M; Hassanein SI; Abdel Rahman MF; Gad MZ
Mol Biol Rep; 2018 Dec; 45(6):2411-2419. PubMed ID: 30284143
[TBL] [Abstract][Full Text] [Related]
5. Plasma ADMA predicts restenosis of arteriovenous fistula.
Wu CC; Wen SC; Yang CW; Pu SY; Tsai KC; Chen JW
J Am Soc Nephrol; 2009 Jan; 20(1):213-22. PubMed ID: 19118151
[TBL] [Abstract][Full Text] [Related]
6. Correlation of pre-existing vascular pathology with arteriovenous graft outcomes in hemodialysis patients.
Allon M; Litovsky S; Young CJ; Deierhoi MH; Goodman J; Hanaway M; Lockhart ME; Robbin ML
Am J Kidney Dis; 2013 Dec; 62(6):1122-9. PubMed ID: 23746379
[TBL] [Abstract][Full Text] [Related]
7. Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes.
Abhary S; Burdon KP; Kuot A; Javadiyan S; Whiting MJ; Kasmeridis N; Petrovsky N; Craig JE
PLoS One; 2010 Mar; 5(3):e9462. PubMed ID: 20209122
[TBL] [Abstract][Full Text] [Related]
8. Circulating methylarginine levels and the decline in renal function in patients with chronic kidney disease are modulated by DDAH1 polymorphisms.
Caplin B; Nitsch D; Gill H; Hoefield R; Blackwell S; MacKenzie D; Cooper JA; Middleton RJ; Talmud PJ; Veitch P; Norman J; Wheeler DC; Leiper JM
Kidney Int; 2010 Mar; 77(5):459-67. PubMed ID: 20010544
[TBL] [Abstract][Full Text] [Related]
9. Transcriptomics of Human Arteriovenous Fistula Failure: Genes Associated With Nonmaturation.
Martinez L; Tabbara M; Duque JC; Selman G; Falcon NS; Paez A; Griswold AJ; Ramos-Echazabal G; Hernandez DR; Velazquez OC; Salman LH; Vazquez-Padron RI
Am J Kidney Dis; 2019 Jul; 74(1):73-81. PubMed ID: 30826088
[TBL] [Abstract][Full Text] [Related]
10. Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.
Hu X; Atzler D; Xu X; Zhang P; Guo H; Lu Z; Fassett J; Schwedhelm E; Böger RH; Bache RJ; Chen Y
Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1540-6. PubMed ID: 21493890
[TBL] [Abstract][Full Text] [Related]
11. Severe Endothelial Damage in Chronic Kidney Disease Patients Prior to Haemodialysis Vascular Access Surgery.
Pushevski V; Dejanov P; Gerasimovska V; Petrushevska G; Oncevski A; Sikole A; Popov Z; Ivanovski N
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(3):43-9. PubMed ID: 27442395
[TBL] [Abstract][Full Text] [Related]
12. Vascularization of the arteriovenous fistula wall and association with maturation outcomes.
Duque JC; Martinez L; Tabbara M; Parikh P; Paez A; Selman G; Salman LH; Velazquez OC; Vazquez-Padron RI
J Vasc Access; 2020 Mar; 21(2):161-168. PubMed ID: 31608758
[TBL] [Abstract][Full Text] [Related]
13. Clinical Outcomes of Arteriovenous Access in Incident Hemodialysis Patients with Medicare Coverage, 2012-2014.
Bylsma LC; Reichert H; Gage SM; Roy-Chaudhury P; Nordyke RJ; Fryzek J; Dahl SLM; Lithgow T; Lawson JH
Am J Nephrol; 2019; 49(2):156-164. PubMed ID: 30677763
[TBL] [Abstract][Full Text] [Related]
14. DDAH1 and DDAH2 polymorphisms associate with asymmetrical dimethylarginine plasma levels in erectile dysfunction patients but not in healthy controls.
Brites-Anselmi G; Azevedo AMM; Miyazaki AHL; Pinheiro LC; Coeli-Lacchini FB; de Andrade MF; Molina CAF; Tucci S; Hirsch E; Tanus-Santos JE; Lacchini R
Nitric Oxide; 2019 Nov; 92():11-17. PubMed ID: 31394201
[TBL] [Abstract][Full Text] [Related]
15. A Retrospective Case-Control Study on Late Failure of Arteriovenous Fistula in Hemodialysis Patients and Prediction of Risk Factors.
Ge L; Fang Y; Rao S
Comput Math Methods Med; 2022; 2022():8110289. PubMed ID: 35309838
[TBL] [Abstract][Full Text] [Related]
16. Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA).
Reddy KRK; Dasari C; Duscharla D; Supriya B; Ram NS; Surekha MV; Kumar JM; Ummanni R
Angiogenesis; 2018 Feb; 21(1):79-94. PubMed ID: 29150732
[TBL] [Abstract][Full Text] [Related]
17. Reduced Renal Methylarginine Metabolism Protects against Progressive Kidney Damage.
Tomlinson JA; Caplin B; Boruc O; Bruce-Cobbold C; Cutillas P; Dormann D; Faull P; Grossman RC; Khadayate S; Mas VR; Nitsch DD; Wang Z; Norman JT; Wilcox CS; Wheeler DC; Leiper J
J Am Soc Nephrol; 2015 Dec; 26(12):3045-59. PubMed ID: 25855779
[TBL] [Abstract][Full Text] [Related]
18. Effect of asymmetric dimethylarginine (ADMA) on heart failure development.
Liu X; Hou L; Xu D; Chen A; Yang L; Zhuang Y; Xu Y; Fassett JT; Chen Y
Nitric Oxide; 2016 Apr; 54():73-81. PubMed ID: 26923818
[TBL] [Abstract][Full Text] [Related]
19. New Insights into Dialysis Vascular Access: Impact of Preexisting Arterial and Venous Pathology on AVF and AVG Outcomes.
Vazquez-Padron RI; Allon M
Clin J Am Soc Nephrol; 2016 Aug; 11(8):1495-1503. PubMed ID: 27401525
[TBL] [Abstract][Full Text] [Related]
20. Fibrotic Venous Remodeling and Nonmaturation of Arteriovenous Fistulas.
Martinez L; Duque JC; Tabbara M; Paez A; Selman G; Hernandez DR; Sundberg CA; Tey JCS; Shiu YT; Cheung AK; Allon M; Velazquez OC; Salman LH; Vazquez-Padron RI
J Am Soc Nephrol; 2018 Mar; 29(3):1030-1040. PubMed ID: 29295872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
